AU2001258569A1 - Alzheimer's disease assay - Google Patents
Alzheimer's disease assayInfo
- Publication number
- AU2001258569A1 AU2001258569A1 AU2001258569A AU5856901A AU2001258569A1 AU 2001258569 A1 AU2001258569 A1 AU 2001258569A1 AU 2001258569 A AU2001258569 A AU 2001258569A AU 5856901 A AU5856901 A AU 5856901A AU 2001258569 A1 AU2001258569 A1 AU 2001258569A1
- Authority
- AU
- Australia
- Prior art keywords
- alzheimer
- disease assay
- assay
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/44—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving esterase
- C12Q1/46—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving esterase involving cholinesterase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4709—Amyloid plaque core protein
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2814—Dementia; Cognitive disorders
- G01N2800/2821—Alzheimer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0012123 | 2000-05-20 | ||
GB0012123A GB0012123D0 (en) | 2000-05-20 | 2000-05-20 | Alzheimer's disease assay |
PCT/GB2001/002229 WO2001090757A1 (en) | 2000-05-20 | 2001-05-21 | Alzheimer's disease assay |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001258569A1 true AU2001258569A1 (en) | 2001-12-03 |
Family
ID=9891920
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001258569A Abandoned AU2001258569A1 (en) | 2000-05-20 | 2001-05-21 | Alzheimer's disease assay |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2001258569A1 (en) |
GB (1) | GB0012123D0 (en) |
WO (1) | WO2001090757A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MY137266A (en) * | 2002-12-18 | 2009-01-30 | Inst Medical Res | Acetylcholinesterase assay |
WO2012142301A2 (en) | 2011-04-12 | 2012-10-18 | Quanterix Corporation | Methods of determining a treatment protocol for and/or a prognosis of a patients recovery from a brain injury |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5595883A (en) * | 1990-06-01 | 1997-01-21 | E. R. Squibb & Sons, Inc. | Method of diagnosing alzheimer's disease by measuring acetylcholinesterase activity in ocular fluid |
EP0567564B1 (en) * | 1991-01-18 | 1996-10-16 | ESA, Inc. | Method for diagnosing disorders from biochemical profiles |
CA2183901A1 (en) * | 1996-08-22 | 1998-02-23 | Johanna E. Bergmann | Targets for therapy and diagnosis of alzheimer's disease and down syndrome in humans |
US5976817A (en) * | 1996-10-31 | 1999-11-02 | Trustees Of Boston University | Diagnostic method for detecting Alzheimer's disease in living patients |
AU1153300A (en) * | 1998-10-23 | 2000-05-15 | Roger Nitsch | Methods of diagnosing or prognosing alzheimer's disease |
-
2000
- 2000-05-20 GB GB0012123A patent/GB0012123D0/en not_active Ceased
-
2001
- 2001-05-21 WO PCT/GB2001/002229 patent/WO2001090757A1/en active Application Filing
- 2001-05-21 AU AU2001258569A patent/AU2001258569A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
GB0012123D0 (en) | 2000-07-12 |
WO2001090757A1 (en) | 2001-11-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001233299A1 (en) | Methods for treating alzheimer's disease | |
AU2002219824A1 (en) | Compositions and methods for diagnosing alzheimer's disease | |
AU2001273132A1 (en) | Compounds to treat alzheimer's disease | |
AU2610901A (en) | Predictive diagnostic for alzheimer's disease | |
AU2002335794A1 (en) | Allylamides useful in the treatment of alzheimer's disease | |
AU2001281034A1 (en) | Alzheimer's tester | |
AU2001292388A1 (en) | Men's brief | |
AU2001236592A1 (en) | Methods for diagnosis of alzheimer's disease | |
AU2001273661A1 (en) | Methods of screening for alzheimer's disease | |
AUPQ715700A0 (en) | The men's urinal | |
AU3068899A (en) | Diagnostic assay for late-onset alzheimer's disease | |
AU2001248760A1 (en) | Preventives/remedies for alzheimer's disease | |
AU2001232132A1 (en) | Novel assay | |
AU2001232041A1 (en) | Improved assay | |
AU2001258569A1 (en) | Alzheimer's disease assay | |
AU2001240793A1 (en) | Novel assay | |
AU2002242348A1 (en) | Process for obtaining 3'-epilutein | |
AU2001267826A1 (en) | Remedies for alzheimer's disease | |
AUPQ556700A0 (en) | Child's blanket | |
AU2001273675A1 (en) | Methods and assays for diagnosing alzheimer's disease | |
GB0020083D0 (en) | Assay 14 | |
AU2002364885A1 (en) | Alzheimer's disease model | |
AU2002221623A1 (en) | Gene 4 | |
AU2001238707A1 (en) | 32705, 23224, 27423, 32700, 32712, novel human g-proteins | |
AU2001296584A1 (en) | Alzheimer's disease-associated proteins |